Illumina

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. 

CEO
Jacob Thaysen
CEOJacob Thaysen
Employees
10,370
Employees10,370
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
10,370
Employees10,370

ILMN Key Statistics

Market cap
18.35B
Market cap18.35B
Price-Earnings ratio
27.03
Price-Earnings ratio27.03
Dividend yield
Dividend yield
Average volume
1.75M
Average volume1.75M
High today
$122.79
High today$122.79
Low today
$118.59
Low today$118.59
Open price
$119.15
Open price$119.15
Volume
1.59M
Volume1.59M
52 Week high
$153.06
52 Week high$153.06
52 Week low
$68.70
52 Week low$68.70

Stock Snapshot

The current Illumina(ILMN) stock price is $120.08, with a market capitalization of 18.35B. The stock trades at a price-to-earnings (P/E) ratio of 27.03.

During the trading session on 2025-11-18, Illumina(ILMN) shares reached a daily high of $122.79 and a low of $118.59. At a current price of $120.08, the stock is +1.3% higher than the low and still -2.2% under the high.

Trading volume for Illumina(ILMN) stock has reached 1.59M, versus its average volume of 1.75M.

The stock's 52-week range extends from a low of $68.70 to a high of $153.06.

The stock's 52-week range extends from a low of $68.70 to a high of $153.06.

ILMN News

Simply Wall St 10h
The Bull Case For Illumina Could Change Following Export Ban Easing in China—Learn Why

Earlier this month, the Chinese Ministry of Commerce lifted its export ban on Illumina, Inc., though the company remains on the Unreliable Entities List, requir...

The Bull Case For Illumina Could Change Following Export Ban Easing in China—Learn Why
Simply Wall St 3d
A Look at Illumina Valuation After China Ban Lift and Whole-Genome Breakthrough

Illumina (ILMN) is back in the spotlight after the publication of a groundbreaking whole-genome sequencing study in Nature and the Chinese export ban on its pro...

A Look at Illumina Valuation After China Ban Lift and Whole-Genome Breakthrough
Simply Wall St 4d
Does the Recent 29% Rally Signal a New Opportunity for Illumina Stock?

Ever wondered if Illumina could be a hidden gem, potentially undervalued and offering an opportunity that others might be missing? Despite a recent 29.0% surge...

Does the Recent 29% Rally Signal a New Opportunity for Illumina Stock?

Analyst ratings

45%

of 22 ratings
Buy
40.9%
Hold
45.5%
Sell
13.6%

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.